In the news / Respiratory

NEWS
With the rise of the highly transmissible COVID-19 Delta variant, stories surrounding breakthrough cases of vaccinated people continue to surface. Researchers remind us that vaccines reinforce the defenses we already have, so that we can encounter the virus safely and potentially build further upon that protection.
 
NEWS
Despite slowdowns in research suffered by universities around the world due to the pandemic, the University of Arizona has experienced solid growth in the commercialization of university inventions. In the last fiscal year alone UArizona received 274 invention disclosures and launched 17 startups.
 
NEWS
The AZ HEROES study of COVID-19 vaccine effectiveness and immunity among frontline workers has received a $15 million award from the CDC to continue the current research for another year and expand to include children and focus on underserved populations.
 
NEWS
Scientists continue to investigate how COVID-19 affects our senses and changes the way we interact with society. Dr. Katalin Gothard says the isolation that comes with COVID-19 especially impacts our sense of touch. She is also studying how COVID-19 is changing our brain chemistry.
 
NEWS
Dr. Deepta Bhattacharya says the original COVID-19 Delta variant is more transmissible than anything we’ve seen before. Now, it mutated to delta plus, which seems to make it harder for antibodies to block it from entering a cell. Dr. Bhattacharya says the vaccines we have should provide protection from delta plus.
 
NEWS
In a time when the delta variant of the COVID-19 virus is rapidly gaining traction, full vaccination offers a much better firewall against infection than partial vaccination. Dr. Michael Worobey agrees the virus has not run out of moves. Experiments found that fully vaccinated people — with the recommended regimen of two shots of the Pfizer-BioNTech or AstraZeneca vaccine — should retain significant protection against the delta variant.
 
NEWS
Reaching the elusive herd immunity in Pima County has proven difficult as vaccine administration steadily decreased beginning in April. While some people remain hesitant to get a shot or simply are refusing to do so, health officials attribute the struggle to vaccinate to a lack of access.
 
NEWS
A just-published report that included data from the University of Arizona AZ Heroes study found that those who contract COVID-19 after vaccination are likely to have a lower viral load, have a shorter infection time and experience milder symptoms than those who didn't receive a vaccine.
 
NEWS
Real-world data from the AZ HEROES study show COVID-19 vaccines are highly effective in preventing SARS-CoV-2 infections, and when breakthrough infections do occur, the level of infection and impact of the disease are significantly reduced. Dr. Jeff Burgess says that in addition to continuing research into COVID-19 immunity and vaccine efficacy, AZ HEROES researchers are beginning to examine the frequency of SARS-CoV-2 variants.
 
NEWS
Results of the AZ HEROES study show those who contract COVID-19 after vaccination have lower viral load, shorter infection, and milder symptoms compared to the unvaccinated. The study followed Arizona first responders, health care workers, and other essential frontliners.
 
NEWS
Researchers at the University of Arizona will be launching a study of how prone Hispanic children are to asthma in Tucson compared with their peers on the other side of the U.S.-Mexico border in Nogales, Sonora. The study will follow 500 pregnant women of Mexican descent in both cities and their newborns for the next five years to see how prevalent asthma is.
 
NEWS
Twenty-five years ago, Dr. John Galgiani took his knowledge of Valley Fever to the AZ Board of Regents which authorized the creation of the University of Arizona Valley Fever Center for Excellence. Today, Valley Fever is much better understood because of UArizona researchers dedication to develop rapid testing, & vaccine for dogs with the hopes a human vaccine could follow.
 
NEWS
Experts say cases of Valley fever, a fungal infection common in the desert Southwest, are on the rise. "For every case, it's reported there are probably three or four people who got sick and had an illness from this but the doctors never recognize it," said Dr. John Galgiani, director of the University of Arizona's Valley Fever Center for Excellence.
 
NEWS
Dr. John Galgiani, a professor of medicine in infectious diseases at the College of Medicine – Tucson and director of the Valley Fever Center for Excellence, is hopeful that a Valley fever vaccine for dogs may lay the groundwork for another human candidate.
 
NEWS
On World Asthma Day, we applaud the innovative and translational lung research conducted by our BIO5 Institute members.
 
NEWS
Dr. Fernando Martinez, director of the Asthma & Airway Disease Research Center at UArizona and BIO5 member, is investigating the link between hygiene and asthma in children in Tucson and Nogales, Mexico. Dr.
 
NEWS
Dr. Monica Kraft, professor and chair of the College of Medicine – Tucson’s Department of Medicine, deputy director of the Asthma and Airway Disease Research Center, and BIO5 faculty, has received the Paul Harris Fellowship Award from Rotary International for her contributions to precision medicine as both principal investigator for the University of Arizona – Banner Health All of Us Research Program and a renowned basic and translational physician-scientist specializing in precision medicine therapies to treat severe asthma.
 
NEWS
University of Arizona students are taking part in a nationwide study involving more than 20 college campuses that aims to understand whether people vaccinated against COVID-19 can still transmit the disease as asymptomatic carriers. The study’s principal investigator, Dr. Elizabeth Connick, BIO5 member and UArizona chief of the Infectious Diseases Division explained how the study is being conducted and how the findings can serve the ultimate goal of ending the pandemic.